Concerns rise among Korean drug makers

The domestic pharmaceutical sector is expected to face an inevitable blow with major drug companies from the United States taking a stronger hold of the local market following if a U.S.-Korea free trade agreement goes through.

The government on Tuesday approved a bill calling for assessing the violation of patents when it reviews applications by local drug makers for the sale of copied drugs...